Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation (2018)
Fonte: Annals of hematology. Unidade: FM
Assuntos: LEUCEMIA, DOENÇAS LINFÁTICAS, PROGNÓSTICO, CROMOSSOMOS HUMANOS, MUTAÇÃO, DELEÇÃO DE GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUCCHERI, Valeria et al. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Annals of hematology, v. 97, n. 12, p. 2269-2278, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00277-018-3503-6. Acesso em: 27 jun. 2025.APA
Buccheri, V., Barreto, W. G., Fogliatto, L. M., Capra, M., Marchiani, M., & Rocha, V. G. (2018). Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Annals of hematology, 97( 12), 2269-2278. doi:10.1007/s00277-018-3503-6NLM
Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M, Rocha VG. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation [Internet]. Annals of hematology. 2018 ; 97( 12): 2269-2278.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1007/s00277-018-3503-6Vancouver
Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M, Rocha VG. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation [Internet]. Annals of hematology. 2018 ; 97( 12): 2269-2278.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1007/s00277-018-3503-6
